Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutation

Fig. 2

Comparison of CNA-based pattern, PD-L1 expression and survival analysis among PMBCL and three subgroups of DLBCL. a, Comparison of CNA-based patterns of driver genes among PMBCL and three subgroups of DLBCL according to the status of JAK2/PD-L2 amplification and MYD88 L265P mutation. b, Comparison of PD-L1 expression (IHC score) among PMBCL and three subgroups of DLBCL. c, Survival curves and cox-regression analysis of OS and PFS among three subgroups of DLBCL after RCHOP-like treatment. d, Representative images of HE(× 200) and PD-L1(× 200) IHC in DLBCL_JAK2/PD-L2_amp and DLBCL_ MYD88_L265P

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us